AAO research
Citation percentiles and documented methodological use supported contributions alongside judging and articles. The AAO remanded for final merits rather than approving.
Decision snapshot
Decision detail | Source-backed value |
|---|---|
Decision ID | AUG062024_01B2203 |
Disposition stated in the source | Director decision withdrawn; remanded for final merits. |
Source location |
Contributions joined judging and scholarly articles
The biostatistician had accepted judging and scholarly-authorship findings. The AAO additionally accepted original contributions of major significance, based on methods used in studies concerning ovarian aging, disease heritability, environmental pollutants, and COVID-19 data.
Source: AUG062024_01B2203 page 3; AUG062024_01B2203 page 4.
Corroborated impact evidence answered the Director’s concern
The record documented a 99.96th citation percentile in biostatistics from 2017 to 2024, five methods articles among the field’s top ten percent by citations, and two among the top one percent. Researchers explained actual methodological use and its value to biobank analysis and cross-population genetic research. The AAO considered that context together; it did not establish a required percentile for other researchers.
Source: AUG062024_01B2203 page 4.
Final merits remained for the Director
The AAO found at least three initial categories satisfied, did not need to decide leading-role or remuneration claims, and remanded because the Director had not conducted final merits. The record still required evaluation for sustained acclaim and top-of-field standing.
Source: AUG062024_01B2203 page 4; AUG062024_01B2203 page 5.
Current framework and related reading
The decisions above are non-precedent assessments of particular records. Historical reasoning is identified as historical; consult current guidance for the present framework.